由ARID1A损失诱导的MAP4酸化使结直肠癌细胞对EMP敏感
Lei Pan1,2, Danzhu Wu1, Yilin He1
1Guangdong Provincial Key Laboratory of Gastroenterology, Department of Gastroenterology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Cell death & disease
|December 8, 2025
概括
失去ARID1A瘤抑制基因会对酸 (EMP) 的易受伤害. 这种化疗药物向MAP4,破坏微小管的动态,并在ARID1A缺乏的癌症中诱导细胞死亡.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症治疗方法 癌症治疗方法
背景情况:
- 在多种癌症中,ARID1A基因的突变性失活驱动了瘤发生.
- ARID1A是开发新型抗癌药物的有前途的治疗标.
研究的目的:
- 为了确定ARID1A缺乏癌症的合成致命药物合作伙伴.
- 阐明ARID1A损失和埃斯特拉穆斯酸 (EMP) 之间的合成致死性背后的机制.
主要方法:
- 使用ARID1A同源结肠直肠癌细胞系和FDA批准的药物库进行了合成致命药物查.
- 研究了微管相关蛋白4 (MAP4) 酸化及其在ARID1A缺乏细胞中的PI3K调节的作用.
主要成果:
- 确定了酸 (EMP) 作为ARID1A.的合成致命合作伙伴.
- 证明ARID1A损失增加了MAP4的酸化,导致微管稳定受损,并依赖于剩余的MAP4活性.
- 表明EMP准MAP4,破坏微管动力学,并诱导ARID1A缺乏细胞中的线粒细胞死亡.
- 揭示了由ARID1A损失激活的PI3K可以酸化MAP4.
结论:
- 通过对MAP4介导的微管子动态的调节失调,ARID1A损失赋予了对EMP的敏感性.
- MAP4是ARID1A缺乏细胞中微管子动态的关键调节者.
- 在ARID1A和EMP之间发现了一种新的合成致命性关系,这提供了一个潜在的治疗策略.
相关概念视频
03:03mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
01:07MAPK Signaling Cascades
7.8K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.8K
01:22PI3K/mTOR/AKT Signaling Pathway
5.3K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.3K
02:23Abnormal Proliferation
5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
02:38Mitogens and the Cell Cycle
7.7K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.7K